Cagrilintide: What It Is and How It's Being Studied for Weight Loss Cagrilintide: The Next Gen Peptide for Weight Loss and Satiety Hubmed Novo Nordisk advances obesity candidate to late stage program after weight loss of less than 12% Current Strategies in Managing Obesity STRIVE Obesity Clinical trials of subcutaneous tirzepatide, retatrutide, and Download Scientific Diagram Once weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double blind, placebo controlled and active controlled, dose finding phase 2 trial The Lancet